More prisoners with hepatitis C are becoming eligible for treatment with effective but costly drugs like Harvoni and Sovaldi from Gilead Sciences Inc., as a result of lawsuits filed by inmates in Massachusetts and Florida.
from WSJ.com: US Business http://ift.tt/2DeJKTB
via IFTTT
No comments:
Post a Comment